About Excelya India Private Limited
Data last updated:
Excelya India Private Limited is a foreign private limited company based in Bangalore, Karnataka, India, a subsidiary of Excelya Group Sas, France. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 18 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2021FTC153204. Its GSTIN is 29AAGCE7093J1Z2 (Karnataka).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Deepu Joseph and Francois Jack Roger Moisson.
Its last annual general meeting (AGM) was held on 26 June 2025, and its latest financial statements are for the year ended 31 December 2024. The registered office is at The Millenia 11th Floor Tower A Nos 1 And 2 Murphy Road Ulsoor, Bangalore, Karnataka, India – 560008.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.01 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹96.46 Lakh (net margin 9.6%) and EBITDA of ₹1.42 Cr (EBITDA margin 14.2%).
The company has about 56 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Excelya.
For more details, the company can be reached via its website excelya.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressThe Millenia 11th Floor Tower A Nos 1 And 2 Murphy Road Ulsoor, Bangalore, Karnataka, India – 560008
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands
Excelya India operates one associated brand: Excelya. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers comprehensive clinical development and medical writing services. | excelya.com |
Financials of Excelya India Private Limited
FY 2024 filings availableExcelya India Private Limited reported revenue of ₹10.01 Cr (up 218% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 218% in the latest year. EBITDA rose 192% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹10.01 Cr | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹1.42 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹96.46 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 14.2% | |
| Net Profit Margin | 9.6% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2021-22, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Excelya India are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Excelya India Private Limited
Excelya India has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepu Joseph | Director | 09 Feb 2022 | 4 Years 8 Months | Current |
| Francois Jack Roger Moisson | Director | 21 Jun 2023 | 3 Years 4 Months | Current |
Peer Comparison
Excelya India Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Excelya India Private Limited this company | ₹10.01 Cr (FY 2023) | •••• | •••• | 218.0% | •••• | Bangalore, Karnataka, India |
| Aakaar Biotechnologies Private Limited | ₹99.29 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Kanpur, Uttar Pradesh, India |
| Somex Research and Health Private Limited | ₹95.52 Lakh (FY 2024) | •••• | •••• | -66.0% | •••• | Jaipur, Rajasthan, India |
| Cytespace Research Private Limited | ₹93.04 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Ahmedabad, Gujarat, India |
| Arkgen Enterprises Private Limited | ₹92.67 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Bangalore, Karnataka, India |
Peers are the companies nearest to Excelya India by revenue, above and below it, in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Excelya India Private Limited is audited by VARMA & VARMA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VARMA & VARMA | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Excelya India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Excelya India Private Limited has a workforce of 56 employees as of Apr 06, 2024.
: available in the company report
Recent Activity
Excelya India Private Limited has 9 board changes on record since 2022: 3 appointments and 6 cessations. The latest: Frederic Roland Paqueville ceased to be Additional Director on 28 Jun 2024.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Excelya India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCE7093J1Z2 | Karnataka | Active | 21 Feb 2022 |
: available in the company report
MCA Filings & Documents
: available in the company report
Related news
Frequently Asked Questions
Excelya India is an active foreign private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 18 October 2021 (5+ years old) and is registered under CIN U73100KA2021FTC153204.
Excelya India has 2 current directors:
- Deepu Joseph - Director
- Francois Jack Roger Moisson - Director
The latest financial statements of Excelya India on record with the MCA are for the year ended 31 December 2024. Its last annual general meeting was held on 26 June 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Excelya India is 29AAGCE7093J1Z2, registered in Karnataka.
The CIN (Corporate Identification Number) of Excelya India is U73100KA2021FTC153204. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Excelya India was incorporated on 18 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Excelya India by revenue are Aakaar Biotechnologies Private Limited, Somex Research and Health Private Limited, Cytespace Research Private Limited, Arkgen Enterprises Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities).
Frederic Roland Paqueville ceased to be Additional Director on 28 Jun 2024. Frederic Roland Paqueville was appointed as Director on 05 Jul 2023. Alan Stuart Morgan ceased to be Director on 22 Jun 2023. Excelya India has 9 board changes on record in total.
Excelya India can be reached through the website excelya.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Excelya India is at The Millenia 11th Floor Tower A Nos 1 And 2 Murphy Road Ulsoor, Bangalore, Karnataka, India – 560008.
Excelya India operates in the pharma industry, in the pharma contract r and d segment.